UK markets closed
NIKKEI 225
39,103.22 +486.12 (+1.26%) HANG SENG
18,868.71 -326.89 (-1.70%) CRUDE OIL
76.87 -0.70 (-0.90%) GOLD FUTURES
2,334.60 -58.30 (-2.44%) DOW
39,057.64 -613.40 (-1.55%) Bitcoin GBP
53,041.60 -1,812.75 (-3.30%)
Dr. Martens plc (3U2.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:13AM CEST. Market open.
| Previous close | 0.9700 |
| Open | 0.9650 |
| Bid | 0.9700 x N/A |
| Ask | 1.0600 x N/A |
| Day's range | 0.9650 - 0.9650 |
| 52-week range | 0.7300 - 1.8900 |
| Volume | |
| Avg. volume | 473 |
| Market cap | 962.026M |
| Beta (5Y monthly) | 0.01 |
| PE ratio (TTM) | 8.04 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.07 (7.02%) |
| Ex-dividend date | 04 Jan 2024 |
| 1y target est | N/A |
- GlobeNewswire
Marathon Partners Calls for Strategic Review Process for Dr. Martens
Recommends that the Board hire an Advisor and Commence a Strategic Review with the Goal of Maximizing Shareholder Value Believes an Auction Process for Dr. Martens would likely Result in a Substantial Acquisition Premium for Shareholders Notes Poor Shareholder Returns since the Initial and Secondary Share Offerings of the Company NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Marathon Partners Equity Management, LLC, a New York-based investment firm, and its affiliated investment funds (collective
© 2024 Yahoo. All rights reserved.